For any questions or inquiries, please feel free to contact us.
FIRST TWO COVID-19 TRIALS APPROVED IN MOLDOVA WITH PRIORITY REVIEW!
On July 21, Moldovan Agency of Medicines and Medical Devices (AMDM, Agentia Medicamentelor si Dispozitivelor Medica...
Video Tour of ARENSIA Research Clinic in Kiev
We are happy to share with you some more positive news from ARENSIA: Remaining fully operational through th...
IMPORTANT UPDATES - COVID-19 relaxation measures and in-person monitoring/site visits at ARENSIA Clinics
We are glad to announce that the state of emergency is no longer in place in Moldova, Ukraine, Romania and Georgia. All ...
ARENSIA begins Clinical Trial Program to test DIFFUSION’s lead drug for the treatment of hospitalized COVID-19 patients
We at ARENSIA are proud to announce today that we have entered into an agreement with Diffusion Pharmaceuticals Inc. (NA...
ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.
MORE
ARENSIA offers exceptional fast recruitment rates for renal and hepatic impaired patients.
MORE
ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.
MOREARENSIA Exploratory Medicine GmbH
Merowingerplatz 1
40225 Düsseldorf
Germany
Legal Representatives
Geschaeftsfuehrer / Managing Director: Dr. Claudia Hesselmann / Dr. Jochen Kraatz
Amtsgericht / Local Court: Düsseldorf, HRB 64937
Umsatzsteuer-Identifikationsnummer gemäß §27a Umsatzsteuergesetz: DE 27629 5755
VIDEO INTRO